Judy Mikovits

Source:greenmedinfo.com

Judy A. Mikovits, PhD, was an ME/CFS researcher and previously the research director at the Whittemore Peterson Institute (WPI). Her research focus now centers mostly on autism.

She is one of the authors of the 2011 case definition, International Consensus Criteria.

XMRV

Dr Mikovits led the team that published a paper suggesting a connection between the XMRV retrovirus and ME/CFS. The XMRV paper was later retracted in 2011. Dr. Mikovits participated in a large study in 2012 that indicated that there was no association between Chronic Fatigue Syndrome/Myalgic Encephalomyelitis and either Xenotropic Murine Leukemia Virus-Related Virus or Polytropic Murine Leukemia Virus.

Arrest & lawsuit

Mikovits was fired from the WPI in 2011. After her departure there was a legal dispute, involving her arrest, with the WPI. Dr Mikovits' case against her critics was dismissed in February 2016.

Book - The Plague

In 2014 Dr Mikovits published a book called Plague about her experiences and research.

Talks & interviews

• 2008, Speaker at the 3th Invest in ME International ME Conference on How Sub Grouping will affect research strategies DVD available
• 2009, Speaker at the 4th Invest in ME International ME Conference on How Sub Grouping will affect research strategies DVD available
• 2010, Speaker at the 5th Invest in ME International ME Conference on Implications of XMRV Research for ME/CFS DVD available
• 04 Feb 2015, Spoonie Radio Episode 07 Guest - Dr. Judy Mikovits Part I - Podcast and Full Text Transcript
• 01 Mar 2015, Spoonie Radio Episode 08 Guest - Dr. Judy Mikovits Part II - Podcast and Full Text Transcript
• 22 Nov 2015, Interview with Dr. Judy Mikovits, PhD
• 14 Dec 2015,Global Freedom Movement presents - Dr. Judy Mikovits Phd
• 2011, Speaker at the 6th Invest in ME International ME Conference on Implications of XMRV Research for ME/CFS DVD available
• 2016, Dr Judy Mikovits "We Are Carrying Potentially Deadly Retroviruses We Acquired Through Vaccination!"

Notable studies in ME/CFS

• 2012, A double-blind, placebo-controlled, randomized, clinical trial of the TLR-3 agonist rintatolimod in severe cases of chronic fatigue syndrome (Full Text)

Learn more

• Wikipedia - Judy Mikovits
• 2009, XMRV explained on Nevada Newsmakers October 2009

See also

• Nevada Center for Biomedical Research
• XMRV

double blinded trial A clinical trial is double blinded if neither the participants nor the researchers know which treatment group they are allocated to until after the results are interpreted. This reduces bias. (Learn more: www.nottingham.ac.uk)

agonist A chemical that binds to the receptor and stimulates it's function, e.g., morphine is an opioid agonist that binds to the opioid receptor, reducing pain. The opposite of an antagonist.

myalgic encephalomyelitis (M.E.) - A disease often marked by neurological symptoms, but fatigue is sometimes a symptom as well. Some diagnostic criteria distinguish it from chronic fatigue syndrome, while other diagnostic criteria consider it to be a synonym for chronic fatigue syndrome. A defining characteristic of ME is post-exertional malaise (PEM), or post-exertional neuroimmune exhaustion (PENE), which is a notable exacerbation of symptoms brought on by small exertions. PEM can last for days or weeks. Symptoms can include cognitive impairments, muscle pain (myalgia), trouble remaining upright (orthostatic intolerance), sleep abnormalities, and gastro-intestinal impairments, among others. An estimated 25% of those suffering from ME are housebound or bedbound. The World Health Organization (WHO) classifies ME as a neurological disease.